NIH-funded research R21 grant

A new treatment to protect the brains of premature infants from injury

Official title: A Novel BDNF Potentiator for the Treatment of Neonatal Brain Injury

Funded at Brown University · NIH-11063171 · Data updated 2026-11-12

This study is testing a new treatment to help protect the brains of premature babies who have low oxygen levels, aiming to improve their brain health and development by using a special compound that boosts important signals in the brain.

More Brain Injury research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBrown University
NIH-funded
Lab location1 site (Providence, United States)
Project startApril 1, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$214,733
NIH project number5R21NS133544-02
Project IDNIH-11063171 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants diagnosed with hypoxic-ischemic encephalopathy.

Less likely to help

Patients who are not premature or do not have hypoxic-ischemic encephalopathy may not benefit from this research.

What this research studies

This research focuses on developing a novel treatment to prevent brain damage in premature infants suffering from hypoxic-ischemic encephalopathy (HIE). The approach involves enhancing the signaling of brain-derived neurotrophic factor (BDNF), which is crucial for brain health and development. By using a specially designed compound that targets specific proteins in the brain, the researchers aim to improve the survival of neurons and reduce damage caused by oxygen deprivation. This innovative strategy seeks to address the limitations of current therapies, which only provide supportive care.

Why it matters

Potential benefit: If successful, this research could lead to a groundbreaking treatment that significantly improves outcomes for infants with brain injuries, potentially reducing the incidence of intellectual impairment and cerebral palsy.

How similar studies have gone: While there have been various approaches to treating neonatal brain injuries, this specific method of enhancing BDNF signaling through targeted compounds is novel and has not been extensively tested in clinical settings.

Where this research is happening

  • Brown University
    Providence, United States
    Active

Researchers

  • Principal investigator: Marshall, John — Brown University
  • Study coordinator: Marshall, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.